首页期刊导航|中华检验医学杂志
期刊信息/Journal information
中华检验医学杂志
中华检验医学杂志

尚红

月刊

1009-9158

cjlm@cma.org.cn

010-85158273

100710

北京市东城区东四西大街42号

中华检验医学杂志/Journal Chinese Journal of Laboratory MedicineCSCD北大核心CSTPCD
查看更多>>1978年9月创刊,中华医学会主办。本刊主要读者群是广大中高级检验医学技术人员、医学实验室科研人员和临床各科医师。作为我国检验医学领域专业人员发表研究成果和进行学术交流的重要平台,深受广大读者喜爱。已经连续7次荣获“百种中国杰出学术期刊”称号,入围“中国期刊方阵”期刊,并多次获得中华医学会优秀期刊奖。主要栏目包括:述评、综述、血液与体液学、临床化学、临床微生物学、临床免疫学、分子诊断、实验室质量管理、试剂与仪器评价、经验与技术交流、病例报告、读者来信、专题笔谈等。特色栏目有展望、对话、临床病例(理)研究、继续教育等,深受广大读者喜爱。
正式出版
收录年代

    传承创新 开放合作 助推检验医学高质量发展

    干岭王传新唐栋
    1-3页
    查看更多>>摘要:我国检验医学实验室检测技术设备、质量管理能力、人才培养及学术水平等方面都取得了长足进步,基本实现了临床检测自动化、科室管理标准化、人才培养学术化。未来大数据、数字化、智能化检验新时代下,如何融合高新技术与前沿理念,以传承创新、开放合作赋能检验医学学科建设是检验工作者面临的重要课题。 Great progress has been achieved in the aspects of national laboratory testing technology and equipments, quality management abilities, personnel training, and academic level et al, which basically realized the automation of clinical testing, the standardization of department management and academic development of talent cultivation. In the new era of big data, digitalization, and intelligent testing in the future, important topics for laboratory medicine staffs to face are how to integrate high and new technology and frontier concepts to inherit and innovate, to open up and cooperate for the purpose of empowerment the construction of laboratory medicine disciplines.

    检验医学传承创新国际化

    电泳技术在检验医学中的应用与发展

    王蓓丽郭玮潘柏申干岭...
    4-6页
    查看更多>>摘要:电泳技术创建于20世纪50年代,经过这些年的发展,已经衍生出许多技术分支,在临床检验与科学研究中发挥着重要作用。自动化、智能化、微量化将推动电泳技术在辅助临床疾病诊疗与机制研究中不断发展前进。 Electrophoresis technique, established in the mid-20th century, has derived many technical branches over many years of development, which plays an important role in clinical laboratory and scientific researches. The automation, intelligence, and miniaturization will promote continuous progress of electrophoresis technology in assisting the diagnosis, treatment and mechanism study of clinical diseases.

    血蛋白电泳检验医学临床实验室技术

    检验医学与生命组学协同发展的机遇和挑战

    于晓波孙爱华王琰贺福初...
    7-13页
    查看更多>>摘要:随着蛋白质组学技术日趋成熟,近年来蛋白质组学在重大疾病的早期检测、疾病分型和药靶发现等领域不断取得重要成果。为深入探讨以蛋白质组学为主的前沿生命组学技术在推动精准检验医学发展中的重要作用和在创新成果临床转化过程中面临的机遇和挑战,国家蛋白质科学中心(北京)邀请来自检验医学、生命组学和精准医疗的知名专家学者,围绕检验医学与生命组学协同发展、临床检验新技术的未来趋势、生命组学对于检验医学的创新和发展、蛋白质组学技术在检验医学中的转化应用和蛋白质组学成果产业化的机遇和挑战等议题分享他们对生命组学技术和成果在检验医学中的经验和看法。大家一致认为蛋白质组学为疾病的精准诊疗提供了新的方向和机遇,但还需产学研紧密合作,同时要解决设备临床适用性、检测方法和数据标准化、成本和质量控制、人才培养和产业化路径等问题。 With the maturation of proteomics technologies in recent years, proteomics has made significant achievements in early detection of major diseases, disease classification, drug target discovery, and other fields. To explore the important role of proteomics, especially proteomics-based cutting-edge lifeomics technologies, in promoting the development of precision laboratory medicine and to discuss the opportunities and challenges faced during the clinical translation of innovative outcomes, the National Center for Protein Sciences-Beijing invited renowned experts and scholars in laboratory medicine, lifeomics, and precision medicine. The discussions revolved around the collaborative development of laboratory medicine and lifeomics, the future trends of new technologies in clinical laboratory testing, the innovation and development of lifeomics in laboratory medicine, the translational application of proteomics technologies in laboratory medicine, and the opportunities and challenges in the industrialization of proteomics achievements. All participants agreed that proteomics provides new directions and opportunities for precision diagnosis and treatment of diseases. However, close collaboration between academia, hospitals and industry is required. Additionally, challenges such as clinical applicability of equipment, standardization of detection methods and data, cost and quality control, talent cultivation, and the industrialization pathway need to be addressed.

    检验医学生命组学蛋白质组学

    毛细管电泳-质谱联用技术及其在检验医学中的应用

    沈佐君干岭
    14-19页
    查看更多>>摘要:毛细管电泳技术具有高灵敏度和高分离效率,质谱技术能够提供样品的结构信息,将毛细管电泳与质谱技术联用,可具有强大的定性和定量分析能力。毛细管电泳-质谱技术的出现,使得人们能在纳升级样品水平,甚至单细胞层面,进行生物活性成分的结构分析和分子量的准确测定,是生物样本分析不可或缺的技术平台。随着该技术的发展,毛细管电泳-质谱分析方法在临床检验领域的应用开始崭露头角。 Capillary electrophoresis has high sensitivity and high separation efficiency, and mass spectrometry can provide structural information of samples. The combination of capillary electrophoresis and mass spectrometry can form powerful capabilities on qualitative and quantitative analysis. The presence of capillary electrophoresis-mass spectrometry makes it possible to accurately analyze the structure and molecular weight of bioactive components at the nanoscale sample level, or even at the single-cell level, which is an indispensable technology platform for the analysis of biological samples. With the development of this technique, the applications of capillary electrophoresis-mass spectrometry began to emerge in the field of clinical testing.

    电泳,毛细管质谱分析法分子结构接口

    以产品注册为目标的实验室自建检测管理模式探讨与分析

    周宏伟陈定强何彦江凌晓...
    20-23页
    查看更多>>摘要:目前,国内实验室自建检测(LDT)管理正处于探索阶段,亟需探讨适应国情发展的新方案和新思路。该文通过剖析遇到的问题,结合政府、医改和患者三方的实际需要,提出“促进LDT项目的良性发展,关注患者利益保护与创新支持的有机结合”是LDT管理的重要方向,并围绕这一方向提出了LDT项目管理的新思路,即以产品注册为目标的LDT管理模式。该管理模式的核心是以产品注册为目标,以低廉的患者服务费用和持续实时的数据监控为保障。利益和风险分析表明,该管理模式可较大程度兼顾患者、医疗机构、体外诊断企业和政府管理部门的现实诉求,有利于促进我国LDT项目的完善与发展。 Currently, the management of domestic laboratory developed test (LDT) is still in the exploration stage, and new plans and ideas need to be investigated that are suitable for our national development. By analyzing encountered issues, combining the actual needs of the government, healthcare reform, and patients, this article proposes that "promoting healthy development of LDT projects and focusing on the organic combination of patients′ interest protection and innovation support" is an important direction for LDT management, around which the new idea for LDT project management is proposed, that is, LDT management model targeting product registration. The core of this management model is to target product registration and to ensure low service fees for patients and continuous real-time data monitoring. Benefit and risk analysis demonstrate that this management model can to a larger extent balance the realistic demands of patients, medical institutions, in vitro diagnostics companies, and government management departments, which benefits promoting the perfection and development of LDT projects in our country.

    管理模式实验室自建检测注册体外诊断

    儿童副流感病毒感染临床实验室诊断专家共识

    尚世强干岭
    24-34页
    查看更多>>摘要:人副流感病毒(HPIV)是引起儿童下呼吸道感染的主要病原体之一,疾病负担严重。目前临床对HPIV感染儿童的危害存在认识不足,实验室也缺乏科学、合理的诊断流程,为此,国家儿童健康与疾病临床医学研究中心和中华医学会儿科学分会临床检验学组组织相关临床与检验专家,从HPIV生物学特性和致病机制、流行病学特征、临床表现、实验室检测、治疗和预防等多个方面进行阐述,提出儿童呼吸道HPIV感染的临床实验室诊断专家建议,旨在为各医院儿童HPIV感染的诊疗和预防提供参考。 Human parainfluenza virus (HPIV) is one of the major pathogens that causes lower respiratory tract infections in children, resulting in a severe disease burden. Currently, there is an inadequate understanding of the clinic on the hazards of HPIV infection in children and a lack of scientific and reasonable diagnostic procedures in laboratories. Therefore, National Clinical Research Center for Child Health and the Clinical Laboratory Group of Chinese Pediatric Society of the Chinese Medical Association have organized relevant experts from clinic and laboratory to expound on the biological characteristics and pathogenic mechanisms of HPIV, epidemiological features, clinical manifestations, laboratory testing, treatment, and prevention, and to put forward expert recommendations on the clinical laboratory diagnosis of respiratory HPIV infection in children, aiming to provide references on diagnosis, treatment and prevention of children′s HPIV infection in respiratory tract for hospitals.

    副流感病毒儿童呼吸道感染实验室诊断

    基于患者数据的实时质量控制程序建立与性能验证专家共识

    王传新杨曦明干岭
    35-48页
    查看更多>>摘要:基于患者数据的实时质量控制(PBRTQC)具有连续监控、低成本、无基质效应、分析前和中误差敏感、体现患者风险等优势,与传统室内质量控制联合应用,可及时有效地检测出系统误差,保证检验结果的准确性。由于PBRTQC算法、参数选择和程序建立的复杂性,目前国内尚缺乏PBRTQC程序建立的方法原则以及优化性能参数设置的共识和标准指南。该共识从PBRTQC项目选择、参数设置、程序建立、参数优化与验证、以及报警处理全流程的应用给出指导建议,以进一步提升实验室质量管理水平,减少患者风险。 Patient-based real-time quality control (PBRTQC) has the advantages of continuity, low cost, no matrix effect, sensitivity to pre-analysis and analysis errors, and the ability to monitor patient risk. It can timely and effectively detect system errors by combining with traditional internal quality control. However, due to the complexity of the algorithm and parameters of PBRTQC, there is no consensus and standard guidelines on the establishment of testing procedures and the optimization of PBRTQC performance parameters. This consensus provides suggestions on the selection of testing items, parameter settings, process establishment, parameter optimization and validation, and alarm handling in PBRTQC to further enhance the level of laboratory quality management and minimize patient risk.

    质量控制临床实验室技术质量管理程序建立共识

    中国广东人群δ地中海贫血基因谱和血液学表型研究

    陈晓俊江帆周剑英李坚...
    49-56页
    查看更多>>摘要:目的 探讨中国广东人群δ珠蛋白(HBD)基因变异谱及δ地中海贫血血液学表型特征。 方法 采用回顾性病例分析研究,收集2020年7月至2022年12月参加广州市免费地中海贫血筛查的11 616对夫妇血液样本,进行血常规和血红蛋白(Hb)毛细管电泳分析,依据以上结果,共154例样本入组研究:(1)HbA2<2.0%且无HbF条带组35例;(2)HbA2<2.0%伴HbF条带组64例;(3)HbA2<2.0%伴可疑HbA2变异体组25例;(4)2.0%≤HbA2<3.5%伴HbF条带且血常规异常[红细胞平均体积(MCV)<82 fl和/或红细胞平均血红蛋白含量(MCH)<27 pg]组25例;(5)2.0%≤HbA2<3.0%伴β地中海贫血基因携带组5例。采用Sanger 测序检测δ珠蛋白基因的单核苷酸变异。 结果 (1)共检出22种HBD基因变异,包括6种新变异,前3位基因变异分别为c.-127T>C(57.02%,65/114)、c.-80T>C(9.65%,11/114)与c.349C>T(7.89%,9/114)。(2)HbA2<2.0%且无HbF条带组检出HBD基因变异22例(62.85%,22/35),其中7例MCV、MCH均低于正常参考值,4例合并α地中海贫血;13例未检出HBD基因变异,其中12例MCV、MCH均明显低于正常参考值。19例血常规异常样本中,HBD基因变异检出异常者(7例)HbA2水平低于未检出者(12例)(P<0.01)。(3)HbA2<2.0%伴HbF条带组检出HBD基因变异59例(92.18%,59/64),均为启动子区变异,59例样本HbF均<5.0%;5例HbF>5.0%样本均未检出HBD基因变异。(4)HbA2<2.0%伴可疑HbA2变异体组HBD基因变异检出率为100%(25/25),δ珠蛋白变异体值<1.0%。(5)2.0%≤HbA2<3.5%伴HbF条带且血常规异常组未检出HBD基因变异。(6)2.0%≤HbA2<3.0%伴β地中海贫血基因携带组5例全部检出HBD基因变异,HbA2值为(2.62±0.17)%,HbF值(3.62±2.22)%。 结论 HBD基因变异类型多样,c.-127T>C是中国广东人群最常见类型;启动子区突变可导致HbA2降低,HbF升高,但HbF值通常<5.0%,合并β地中海贫血可能>5.0%。本研究丰富了广东人群HBD基因突变谱。 Objective To investigate genetic variation profiles of δ-globin (HBD gene) and hematological phenotypes in Guangdong population. Methods Retrospective case analysis was performed in this study. Blood samples of 11 616 couples who participated in free thalassemia screening in Guangzhou from July 2020 to December 2022 were collected which underwent blood routine tests and hemoglobin (Hb) capillary electrophoresis. According to the results, 154 samples were enrolled in this study: (1)group of 35 cases with HbA2 <2.0% but no HbF band (2)group of 64 cases with HbA 2 < 2.0% and HbF band (3)group of 25 cases with HbA 2 <2.0% and suspected HbA 2 variants (4) group of 25 cases with HbA2 ≥2.0% and <3.5% and HbF band, as well as abnormal blood routine report [mean corpuscular volume (MCV) <82 fl and/or mean corpuscular hemoglobin (MCH) <27 pg] (5)group of 5 cases with HbA 2 ≥2.0% and <3.0% accompanied with β thalassemia gene carriers Sanger sequencing was used to detect single nucleotide variants of δ-globin. Results (1) A total of 22 genetic variations were detected, including 6 de novo variations, and the top 3 genetic variations were respectively c.-127T>C (57.02%, 65/114), c.-80T>C (9.65%, 11/114), c.349C>T (7.89%, 9/114). (2) In group of patients with HbA2 <2.0% but no HbF band, 22 cases (62.85%, 22/35) had HBD gene variation, including 7 cases with MCV and MCH lower than reference values, 4 cases with α thalassemia 13 cases had no HBD gene variation, including 12 cases with lower MCV and MCH. Among 19 cases with abnormal blood routine test results, levels of HbA 2 in patients (7 cases) with HBD gene variation were lower compared with those without HBD gene variation (12 cases) (P<0.01%). (3)In group of patients with HbA2<2.0% with HbF band, 59 cases (92.18%, 59/64) had HBD gene variations whose mutations all occurred in promoter region, and the HbF were all lower than 5.0% 5 cases with HbF >5.0% had no HBD gene variation. (4) In group of patients with HbA2 <2.0% and suspected HbA 2 variants, the detection rate was 100% (25/25) and δ-globin variants <1.0%. (5) In group of patients with HbA 2 ≥2.0% and <3.5% and HbF band accompanied with abnormal blood routine results, no HBD gene variation was found. (6) In group of 5 patients with HbA 2 ≥2.0% and <3.0% with β thalassemia gene carriers, HBD gene variation were found in all cases, and the level of HbA 2 was (2.62±0.17)% and HbF was (3.62±2.22)%. Conclusions There are various genotypes of HBD gene variation, among which HBD: c.-127T>C is the most common in Guangdong population in China. Mutations in the promoter region may cause decrease in HbA2 and increase in HbF which is mostly less than 5% but exceeds 5.0% when combined with β thalassemia. Our study enriched the gene mutation profiles of HBD gene in Guangdong population.

    地中海贫血珠蛋白基因异常血红蛋白基因表达谱表型

    神经系统疾病患者3 217例寡克隆区带检测结果分析

    钮振宇金海强郝洪军郑艺明...
    57-64页
    查看更多>>摘要:目的 研究各神经系统疾病的寡克隆区带(OCB)阳性率及分型,提示OCB的临床意义及应用价值。 方法 回顾性分析2012年1月至2022年8月于北京大学第一医院行脑脊液及血清OCB检测的3 217例神经系统疾病患者的检测结果。根据出院诊断分为多发性硬化(479例)、视神经脊髓炎谱系疾病(935例)、自身免疫性脑炎(192例)、病毒性脑炎(94例)、造血干细胞移植后神经系统并发症(232例)、格林-巴利综合征(644例)及慢性炎性脱髓鞘性多发性神经根神经病(157例)等13组。使用等电聚焦电泳结合免疫固定法检测患者同期采集的脑脊液及血液样本中的OCB,依据形态学结果将其分为Ⅰ~Ⅴ型,分析各组患者脑脊液OCB阳性率及分型情况。计数资料采用χ 2检验进行组间比较。 结果 多发性硬化、造血干细胞移植后神经系统并发症、自身免疫性脑炎、病毒性脑炎、视神经脊髓炎谱系疾病、格林-巴利综合征及慢性炎性脱髓鞘性多发性神经根神经病组的脑脊液OCB阳性率分别为66.8%(320/479)、48.7%(113/232)、46.4%(89/192)、19.1%(18/94)、17.6%(165/935)、9.9%(64/644)和5.1%(8/157)。其中,多发性硬化、自身免疫性脑炎、病毒性脑炎及视神经脊髓炎谱系疾病组脑脊液OCB阳性患者以Ⅱ型区带为主,分别占阳性患者的94.1%(301/320)、78.7%(70/89)、77.8%(14/18)和77.6%(128/165),提示存在IgG鞘内合成;造血干细胞移植后神经系统并发症、格林-巴利综合征及慢性炎性脱髓鞘性多发性神经根神经病组脑脊液OCB阳性患者以Ⅳ型区带为主,分别占阳性患者的94.7%(107/113)、82.8%(53/64)和8/8,反映无明显鞘内IgG合成。各组患者脑脊液OCB阳性率比较,差异有统计学意义(χ2=1 268.31,P<0.001)。 结论 各组神经系统疾病脑脊液OCB阳性率不同,其中多发性硬化的患者脑脊液OCB阳性率较高,且以Ⅱ型区带为主,提示脑脊液OCB检测及分型可对多种神经系统疾病,尤其是多发性硬化的诊断提供线索和帮助。 Objective To study positive rates and typing of oligoclonal bands (OCB) in patients with neurological disorders, and to reveal the clinical significance and applicational value of OCB test. Methods A retrospective analysis was performed on the detection results of 3 217 patients with neurological disorders who undertook both serum and cerebrospinal fluid OCBs in the First Hospital of Peking University from January 2012 to August 2022. According to the final diagnosis, the patients were divided into 13 groups including multiple sclerosis (479 cases), neuromyelitis optica spectrum disorders (935 cases), autoimmune encephalitis (192 cases), viral encephalitis (94 cases), nervous system complication after HSCT (232 cases), Guillain-Barré syndrome (644 cases), chronic inflammatory demyelinating polyneuropathy (157 cases), etc. Cerebrospinal fluid and serum OCBs were detected using isoelectric focusing electrophoresis combining immunofixation, then classified into Ⅰ-Ⅴ types according to the morphology. Consequently, positive rates and types were analyzed for each group. χ2 test was used for comparison between groups. Results The positive rates of cerebrospinal fluid OCB in multiple sclerosis, nervous system complication after hematopoietic stem cell transplantation (HSCT), autoimmune encephalitis, viral encephalitis, neuromyelitis optica spectrum disorders, Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy were respectively 66.8% (320/479), 48.7% (113/232), 46.4%(89/192), 19.1% (18/94), 17.6% (165/935), 9.9% (64/644), 5.1% (8/157). For patients with multiple sclerosis, neuromyelitis optica spectrum disorders, viral encephalitis, and autoimmune encephalitis, Type Ⅱ bands took the majority of cerebrospinal fluid OCB-positive cases with the rates of 94.1% (301/320), 78.7% (70/89), 77.8% (14/18), and 77.6% (128/165) respectively, indicating intrathecal IgG synthesis for patients with nervous system complication after HSCT, Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, type Ⅳ bands took the majority of cerebrospinal fluid OCB-positive cases with the rates of 94.7% (107/113), 82.8% (53/64) and 100% (8/8), indicating no obvious intrathecal IgG synthesis. The positive rates of cerebrospinal fluid oligoclonal bands were significantly different among all groups (χ2=1 268.31, P<0.001). Conclusion The positive rates of cerebrospinal fluid oligoclonal bands are different among different neurological disorders, in which the positive rate of cerebrospinal fluid OCB is higher with type Ⅱ bands as the majority type in multiple sclerosis, which indicates that the detection and typing of cerebrospinal fluid OCB are helpful for the diagnosis of various neurological diseases, especially for multiple sclerosis.

    寡克隆区带神经系统疾病脑脊液

    血清蛋白电泳筛查单克隆丙种球蛋白533 989例结果分析

    沈若坚邵文琦朱晶沈逸枫...
    65-71页
    查看更多>>摘要:目的 比较不同性别、年龄人群间血清蛋白电泳(SPE)各区带分布差异,探讨血清蛋白电泳筛查单克隆丙种球蛋白(M蛋白)的临床应用。 方法 回顾性分析复旦大学附属中山医院2018年1月至2019年12月533 989例SPE结果,其中住院患者435 479例,为血液内科、肾病科、脊柱外科、内分泌科及风湿免疫科患者;表观健康人群98 510名,为体检健康人群。比较不同性别和年龄段(≤20、21~30、31~40、41~50、51~60、61~70、71~80、81~90、≥91岁)人群的白蛋白、α1球蛋白、α2球蛋白、β1球蛋白、β2球蛋白及γ球蛋白区带差异分布。筛选出10 014例同时完成SPE和免疫固定电泳(IFE)检测的标本,分析SPE各区带及IFE不同条带类型的阳性检出率,以IFE为金标准,评价SPE方法的敏感度和特异度。 结果 不同性别人群的SPE各区带占比差异均无统计学意义(P均>0.05)。表观健康人群、住院患者不同年龄段白蛋白区带占比差异均有统计学意义(表观健康人群:F=5.12,P<0.05;住院患者:F=4.18,P<0.05),且均随年龄的增长而下降;γ球蛋白区带占比随年龄的增长而上升(表观健康人群:F=1.34,P<0.05;住院患者:F=1.24,P<0.05)。SPE检测M蛋白的敏感度为69%(2 098/3 051),特异度97%(6 721/6 963),与IFE法比较,M蛋白阳性检出率差异有统计学意义(χ²=5 049.94,P<0.05);γ球蛋白区M蛋白阳性检出率(21.11%,2 114/10 014)高于β球蛋白区(3.28%,328/10 014)(χ²=90.74,P<0.05)和β-γ球蛋白区(1.63%,163/10 014)(χ²=44.34,P<0.05);γ球蛋白区常见IgG及IgM型条带,其中IgG-κ型占94.1%(995/1 058)、IgG-λ型占94.8%(690/728)、IgM-κ型占89.2%(222/249)、IgM-λ型占83.8%(62/74);β球蛋白区常见IgA型条带,其中IgA-κ型占49.8%(103/207)、IgA-λ型占51.6%(149/289);IgG-κ型在IFE各条带类型中M蛋白的阳性检出率[10.57%(1 058/10 014)]最高,IgM-λ型M蛋白的阳性检出率[0.74%(74/10 014)]最低。 结论 随着年龄增长,SPE的白蛋白区带占比下降,γ球蛋白区带占比上升。IgG、IgM型M蛋白大多聚集于γ球蛋白区带,其中IgG型M蛋白阳性检出率较高,IgA型大多聚集于β球蛋白区带,阳性检出率较低。 Objective To compare the distribution differences of serum protein electrophoresis (SPE) among different gender and age individuals, and to explore the clinical application of SPE screening monoclonal gammopathy. Methods A retrospective analysis was conducted based on the SPE results obtained from 533 989 cases enrolled from January 2018 to December 2019 at Zhongshan Hospital Affiliated to Fudan University. Among these patients, 435 479 inpatients were from departments of hematology, nephrology, spinal surgery, endocrinology, and rheumatology and immunology and 98 510 were apparently healthy individuals. The distributions of albumin, α1 globulin, α2 globulin, β1 globulin, β2 globulin and γ globulin in different gender and age groups (≤20, 21-30, 31-40, 41-50, 51-60, 61-70, 71-80, 81-90, ≥91 years old) were compared. A total of 10 014 cases were selected by immunofixation electrophoresis (IFE). The positive detection rates of different SPE bands and IFE bands were analyzed. The sensitivity and specificity of SPE methods were determined according to IFE results as the gold standard. Results No significant difference was examined in the proportion of SPE bands between different genders (P>0.05). There were statistically significant differences in the proportion of albumin bands between apparently healthy individuals and hospitalized patients at different ages (apparently healthy individuals:F=5.12, P<0.05, inpatients:F=4.18, P<0.05), and all of them decreased with the increase of age. The proportion of γ globulin bands increased with age (apparently healthy individuals:F=1.34, P<0.05 inpatients:F=1.24, P<0.05). The sensitivity of SPE was 69% (2 098/3 051), and the specificity was 97% (6 721/6 963). Compared with IFE method, the positive detection rate of monoclonal gammopathy was significantly different (χ²=5 049.94,P<0.05). The positive rate of monoclonal gammopathy in γ globulin region (21.11%, 2 114/10 014) was higher than that in β globulin region (3.28%, 328/10 014) (χ²=90.74,P<0.05) and β-γ globulin region (1.63%, 163/10 014) (χ²=44.34,P<0.05). IgG and IgM bands are common in γ globulin region. Among them, IgG-κ type accounted for 94.1% (995/1 058), IgG-λ type accounted for 94.8% (690/728), IgM-κ type accounted for 89.2% (222/249), IgM-λ accounted for 83.8% (62/74). IgA bands are common in β region, of which IgA-κ accounted for 49.8% (103/207) and IgA-λ accounted for 51.6% (149/289). The positive rate of monoclonal gammopathy of IgG-κ type was the highest (10.57%, 1 058/10 014), and the positive rate of monoclonal gammopathy of IgM-λ type was the lowest (0.74%, 74/10 014). Conclusions With increasing age, the proportion of albumin band in SPE decreased and the proportion of γ globulin band increased. IgG and IgM type monoclonal gammopathy is mostly found in the gamma region, with a higher detection rate in IgG type. IgA type monoclonal gammopathy is mostly found in the β region, with a lower detection rate.

    血蛋白电泳免疫电泳单克隆丙种球蛋白